NRSN logo
NRSN NASDAQ IL

NeuroSense Therapeutics Ltd. - Ordinary Shares

Healthcare · Biotechnology Website · IPO Dec 2021
$0.83
▲ +$0.07 (+9.21%)
Vol 99K
3
Quality Score
fail
Mkt Cap
$22.8M
ROE
-206.3%
D/E
4.50
Beta
1.55
52W
$1–$3

Wall Street Consensus

10 analysts · Apr 2026
2
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Earnings

Beat rate: 75.0%
Quarter EPS Est EPS Act Surprise
Dec 2024 $-0.12 $-0.06 +$0.06
Sep 2024 $-0.16 $-0.11 +$0.05
Jun 2024 $-0.20 $-0.02 +$0.18
Mar 2024 $-0.21 $-0.35 $-0.14

Fundamentals Trend

Metric 2024-12-31 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -206.3% -206.3% -206.3% -206.3% -206.3%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 4.50 4.50 4.50 4.50 4.50
Current Ratio 2.21 0.21 0.21 0.21 0.21 0.21

Key Ratios

ROA (TTM)
-560.3%
P/B
10.7
EPS (TTM)
$-0.85
52W High
$2.60
52W Low
$0.76
$0.76 52-Week Range $2.60

How does NRSN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

NRSN AAPG ABEO ABOS ABP

NRSN valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
10.7
336% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

NRSN profitability vs Biotechnology peers

ROE
-206.3%
206% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-560.3%
1099% below peers (-46.7%)
vs Peers
vs Industry
Weak

NRSN financial health vs Biotechnology peers

D/E ratio
4.5
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.2
95% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.6
59% above peers (1.0)
vs Peers
vs Industry
More volatile

NRSN fundamentals radar

NRSN Peer median Industry

NRSN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

NRSN vs peers: key metrics

Latest News

No related news yet